GlaxoSmithKline PLC (NYSE:GSK)

40.05
Delayed Data
As of May 21
 +0.02 / +0.05%
Today’s Change
34.52
Today|||52-Week Range
44.54
+12.91%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$99.3B

Company Description

GlaxoSmithKline Plc is a global healthcare company which engages in developing, manufacturing, and marketing of pharmaceutical products including vaccines, over the counter medicines and health-related consumer products. It operates through the following segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare. The Pharmaceuticals segment researches, develops and makes available medicines that treat a variety of serious and chronic diseases. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis. The Consumer Healthcare segment markets a range of consumer health products based on scientific innovation. The company was founded on December 6, 1999 and is headquartered in Brentford, the United Kingdom.

Contact Information

GlaxoSmithKline Plc
980 Great West Road
Brentford Greater London TW8 9GS
P:442080475000
Investor Relations:

Employees

Shareholders

Other institutional7.94%
Mutual fund holders3.34%
Individual stakeholders--

Top Executives

Emma WalmsleyChief Executive Officer & Executive Director
Simon DingemansChief Financial Officer & Executive Director
Karenann K. TerrellChief Technology & Digital Officer
Hal V. BarronExecutive Director & Chief Scientific Officer
Nick HironsSenior VP-Global Ethics & Compliance Officer